Welcome to LookChem.com Sign In|Join Free

CAS

  • or

150840-27-0

Post Buying Request

150840-27-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

150840-27-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 150840-27-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,0,8,4 and 0 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 150840-27:
(8*1)+(7*5)+(6*0)+(5*8)+(4*4)+(3*0)+(2*2)+(1*7)=110
110 % 10 = 0
So 150840-27-0 is a valid CAS Registry Number.

150840-27-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-[[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carbonyl]amino]hexanoic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:150840-27-0 SDS

150840-27-0Downstream Products

150840-27-0Relevant articles and documents

Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors

Dang, Zhao,Lai, Weihong,Qian, Keduo,Ho, Phong,Lee, Kuo-Hsiung,Chen, Chin-Ho,Huang, Li

experimental part, p. 7887 - 7891 (2010/04/30)

Wepreviously reported that [[N-[3β-hydroxyllup-20(29)-en-28-oyl]-7- aminoheptyl]carbamoyl]methane (A43D, 4) was a potent HIV-1 entry inhibitor. However, 4 was inactive against HIV-2 virus, suggesting the structural requirements for targeting these two ret

Lupane derivatives, their preparation and the pharmaceutical compositions which contain them

-

, (2008/06/13)

The present invention relates to new lupane dervivatives of the general formula: STR1 to their salts, to their preparation and to the pharmaceutical compositions which contain them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 150840-27-0